Saturday, December 28, 2019 6:07:46 PM
Admittedly it is rather arbitrary but it does stem from the prior discussions of others assuming buy-out happening post MK approval, due to people referring to age of the C level management and the board of directors that will want to 'cash-out' asap.
I submit that this is not likely as none of them are really short on cash, and for a decent understanding of MK's potential market availability and market penetration if good results, then we should be relatively clear on this by 3 years post MK approval. At which point CVM would be at about 60% at least of peak price based on the H&N cancer indication alone, and the price would be stratospherically higher than just after MK approval. Thus would make sense for the C level and Board to cash-out at least 3 years after MK approval I would think.
So rather arbitrary, but makes more sense to me than immediate cash-out.
And if the Phase III results are poor, then the value of the company essential goes to nothing for the foreseeable future.
I submit that this is not likely as none of them are really short on cash, and for a decent understanding of MK's potential market availability and market penetration if good results, then we should be relatively clear on this by 3 years post MK approval. At which point CVM would be at about 60% at least of peak price based on the H&N cancer indication alone, and the price would be stratospherically higher than just after MK approval. Thus would make sense for the C level and Board to cash-out at least 3 years after MK approval I would think.
So rather arbitrary, but makes more sense to me than immediate cash-out.
And if the Phase III results are poor, then the value of the company essential goes to nothing for the foreseeable future.
Recent CVM News
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/27/2026 09:00:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 12:03:20 PM
- CEL-SCI Reports Fiscal Second Quarter 2026 Results • Business Wire • 05/18/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:44:06 PM
- CEL-SCI Announces Closing of Public Offering • Business Wire • 05/13/2026 07:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/12/2026 04:15:05 AM
- CEL-SCI Corporation Announces Pricing of Public Offering • Business Wire • 05/12/2026 12:11:00 AM
- CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia • Business Wire • 05/11/2026 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:03:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 10:59:38 AM
- CEL-SCI Reports Fiscal First Quarter 2026 Results • Business Wire • 02/18/2026 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 10:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 01:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:26:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:23:02 PM
- CEL-SCI Reports Fiscal 2025 Results • Business Wire • 12/29/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 01:48:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 10:00:37 PM
